We report here the first pharmacokinetic-pharmacodynamic relationship for ceftaroline in a preterm infant born at <28 weeks' gestational age who was given ceftaroline (8.5 mg/kg every 8 hours) for pneumonia attributable to methicillin-resistant Staphyloccocus aureus. This dose of ceftaroline was adequate to achieve the pharmacodynamic endpoint associated with efficacy for methicillin-resistant Staphyloccocus aureus.
|Original language||English (US)|
|Number of pages||4|
|Journal||Journal of the Pediatric Infectious Diseases Society|
|State||Published - Dec 3 2018|
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Infectious Diseases